Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image

Digestive Diseases and Sciences

Volumn 51, Issue 5, 2006, Pages 982-985

  Riley III, Thomas R ^a,b   Mendoza, Alfredo ^a   Bruno, Michael A ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Department of Radiology ^*  (United States)

Author keywords

Diagnosis; Fatty liver; Hepatitis; Liver; Steatosis; Ultrasound

Indexed keywords

ADULT; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; NONALCOHOLIC FATTY LIVER; PREDICTION; PRIORITY JOURNAL; PROTOTYPE; RELIABILITY; SENSITIVITY AND SPECIFICITY; ULTRASOUND; ULTRASOUND SCANNER;

FATTY LIVER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; ULTRASONOGRAPHY;

EID: 33745815671     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9343-6     Document Type: Article

References (15)

1. Harrison SA, Torgerson S, Hayashi PH: The natural history of non-alcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 98:2042-2047, 2003
2. Sanyal AJ, Contos MJ, Sterling RK, et al: Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol 98:2064-2071, 2003
3. Angulo P, Keach JC, Batts KP, Lindor KD: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356-1362, 1999
4. Lonardo A, Bellini M, Tondelli E, et al.: Nonalcoholic steatohepatitis and the "bright liver syndrome": should a recently expanded clinical entity be further expanded? Am J Gastroenterololgy 90:2072-2074, 1995
5. Wilson LS, Robinson DE, Griffiths KA, Griffiths KA, Manoharan A, Doust BAD: Evaluation of ultrasonic attenuation in diffuse diseases of spleen and liver. Ultrasonic Imaging 9:236-247, 1994
6. Saverymuttu SH, Joseph AE, Maxwell JD: Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Brit Med J 292:13-15, 1986
7. Sandford NL, Walsh P, Matis C, Baddeley H, Powell LW: Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology 89:186-191, 1985
8. Saadeh S, Younossi ZM, Remer EM, et al.: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123:745-750, 2002
9. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467-2474, 1999
10. Deems RO, Friedman LS, Friedman MI, Munoz SJ, Deems DA, Maddrey WC: Relationship between liver biochemical tests and dietary intake in patients with liver disease. J Clin Gastroenterol 18304-18308, 1994
11. Ueno T, Sugawara H, Sujaku K, et al.: Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27:103-107, 1997
12. Riley TR, Khan A: Risk Factors and ultrasound can predict chronic hepatitis caused by non-alcoholic fatty liver disease. Dig Dis Sci (in press)
13. Riley TR: How often does ultrasound marking change the liver biopsy site? Am J Gastroenterol 94:3320-3322, 1999
14. Riley TR, Bruno MA: Sonographic measurement of the thickness of subcutaneous tissues in non-alcoholic fatty liver disease versus other chronic liver diseases. J Clin Ultrasound 2005 (in press)
15. Ahmad M, Riley TR: Can one predict when ultrasound will be useful with percutaneous liver biopsy? Am J Gastroenterol 96:547-549, 2001